- Home
- WOR vs BCYC Comparison
WOR vs BCYC Comparison
Compare WOR & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOR
- BCYC
- Stock Information
- Founded
- WOR 1955
- BCYC 2009
- Country
- WOR United States
- BCYC United Kingdom
- Employees
- WOR N/A
- BCYC N/A
- Industry
- WOR Aerospace
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- WOR Consumer Discretionary
- BCYC Health Care
- Exchange
- WOR Nasdaq
- BCYC Nasdaq
- Market Cap
- WOR 2.0B
- BCYC 1.7B
- IPO Year
- WOR N/A
- BCYC 2019
- Fundamental
- Price
- WOR $41.99
- BCYC $13.34
- Analyst Decision
- WOR Sell
- BCYC Buy
- Analyst Count
- WOR 2
- BCYC 9
- Target Price
- WOR $46.00
- BCYC $34.50
- AVG Volume (30 Days)
- WOR 352.3K
- BCYC 417.9K
- Earning Date
- WOR 12-17-2024
- BCYC 02-18-2025
- Dividend Yield
- WOR 1.62%
- BCYC N/A
- EPS Growth
- WOR N/A
- BCYC N/A
- EPS
- WOR 0.85
- BCYC N/A
- Revenue
- WOR $1,166,910,000.00
- BCYC $36,898,000.00
- Revenue This Year
- WOR N/A
- BCYC $40.69
- Revenue Next Year
- WOR $3.53
- BCYC N/A
- P/E Ratio
- WOR $49.20
- BCYC N/A
- Revenue Growth
- WOR N/A
- BCYC 48.60
- 52 Week Low
- WOR $37.88
- BCYC $12.17
- 52 Week High
- WOR $69.96
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- WOR 59.78
- BCYC 34.88
- Support Level
- WOR $41.15
- BCYC $13.20
- Resistance Level
- WOR $42.39
- BCYC $15.43
- Average True Range (ATR)
- WOR 1.08
- BCYC 0.89
- MACD
- WOR 0.24
- BCYC 0.16
- Stochastic Oscillator
- WOR 83.97
- BCYC 6.17
About WOR Worthington Enterprises Inc.
Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.